Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure

Keyphrases

• Intestinal Failure 100%
• Pediatric Short Bowel Syndrome 100%
• Teduglutide 100%
• Intravenous Fluids 60%
• Parenteral nutrition 50%
• Volume of Fluid 40%
• Short Bowel Syndrome 40%
• Long-term Extension Study 30%
• Clinical Response 20%
• Pediatric Patients 20%
• Treatment-related Adverse Events 20%
• Old Age 10%
• Bowel 10%
• Colon 10%
• Safety Efficacy 10%
• Long-term Efficacy 10%
• Small Intestine 10%
• Response Predictors 10%
• Long-term Predictors 10%
• Long-term Safety 10%
• Fluid Balance 10%
• Non-white 10%
• White Race 10%
• Multivariate Linear Regression 10%
• Volume Reduction 10%
• Long-term Parenteral nutrition 10%
• Fluid Restriction 10%
• Volume Constraint 10%
• Event Response 10%
• Nutritional Balance 10%

Medicine and Dentistry

• Short Bowel Syndrome 100%
• Intestinal Failure 100%
• Teduglutide 100%
• Pediatrics 100%
• Parenteral Nutrition 60%
• Infusion Fluid 60%
• Patient with Short Bowel Syndrome 30%
• Adverse Event 20%
• Pediatrics Patient 20%
• Post-Hoc Analysis 10%
• Colon 10%
• Linear Regression Analysis 10%
• Small Intestine 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Intestinal Failure 100%
• Teduglutide 100%
• Short Bowel Syndrome 100%
• Infusion Fluid 60%
• Adverse Event 20%